Drugs / pBI-11 DNA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06315257 | Jul 2025 → Jun 2029 expected | cervical cancer | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pBI-11 DNA | “Treatment dose: Arm A: pBI-11 DNA (3 mg) twice via intramuscular (IM) injection” NCT06315257 ↗ |
| Route | Intramuscular | “pBI-11 DNA (3 mg) twice via intramuscular (IM) injection” NCT06315257 ↗ |